119th Congress
H.R. 6867
NIH Clinical Trial Integrity Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Robin L. Kelly(D-IL)
- Introduced
- Dec 18, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (11)
Original cosponsors (1)
- Brian K. Fitzpatrick (R-PA)
Added later (10)
- Eleanor Holmes Norton (D-DC) · Jan 7, 2026
- Gwen Moore (D-WI) · Jan 7, 2026
- Jennifer L. McClellan (D-VA) · Jan 7, 2026
- Mark Pocan (D-WI) · Jan 7, 2026
- Melanie A. Stansbury (D-NM) · Jan 7, 2026
- Paul Tonko (D-NY) · Jan 7, 2026
- Sean Casten (D-IL) · Jan 7, 2026
- Josh Gottheimer (D-NJ) · Jan 13, 2026
- Pramila Jayapal (D-WA) · Jan 15, 2026
- Jason Crow (D-CO) · Jan 21, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
Latest action(Dec 18, 2025): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Dec 18, 2025 · House
Referred to the House Committee on Energy and Commerce. - Dec 18, 2025
Introduced in House